Screener
Organon OGN Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Organon in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Organon’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 8:46 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-029532
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Contingencies (Note 15) | ||
| Organon & Co. Stockholders’ Equity: | ||
| Common stock, $0.01 par valueAuthorized - 500,000Issued and outstanding - 262,649 in 2026 and 260,316 in 2025 | 3 | 3 |
| Additional paid-in capital | 186 | 167 |
| Retained earnings | 1,253 | 1,109 |
| Accumulated other comprehensive loss | (539) | (527) |
| Total Stockholders’ Equity | 903 | 752 |
| Total Liabilities and Stockholders’ Equity | $12,996 | $12,867 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Organon's total equity?
- Organon (OGN) reported total equity of $903M in Q1 2026.
- How has Organon's total equity changed year-over-year?
- Organon's total equity increased by 66.6% year-over-year, from $542M to $903M.
- What is the long-term trend for Organon's total equity?
- Over 5 years (2020 to 2025), Organon's total equity has grown at a -32.8% compound annual growth rate (CAGR), from $5.49B to $752M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Organon's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude